ruxolitinibemapalumabetoposidetocilizumabanakinraprednisoneadult-onset Still’s diseaseautoinflammatory diseasemacrophage activation syndrome (MAS)anti-interleukin-1 therapy
…ory values. The patient was then discharged on a stable dose of ruxolitinib, anakinra and prednisone. This case illustrates the therapeutic…